P Sharplin

630 total citations
14 papers, 519 citations indexed

About

P Sharplin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Epidemiology. According to data from OpenAlex, P Sharplin has authored 14 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Genetics and 3 papers in Epidemiology. Recurrent topics in P Sharplin's work include Diabetes Management and Research (6 papers), Diabetes Treatment and Management (5 papers) and Diabetes and associated disorders (4 papers). P Sharplin is often cited by papers focused on Diabetes Management and Research (6 papers), Diabetes Treatment and Management (5 papers) and Diabetes and associated disorders (4 papers). P Sharplin collaborates with scholars based in United Kingdom, United States and New Zealand. P Sharplin's co-authors include Phil McEwan, Craig J. Currie, Christopher Ll. Morgan, Chris D. Poole, Morten Lammert, Hannele Yki‐Järvinen, Hans‐Ulrich Häring, Peter R. Mullins, Matthew C. Riddle and Patrick J. Kelly and has published in prestigious journals such as Child Abuse & Neglect, Diabetes Research and Clinical Practice and Clinical Therapeutics.

In The Last Decade

P Sharplin

14 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Sharplin United Kingdom 8 410 120 105 68 54 14 519
Barrie Chubb United Kingdom 17 517 1.3× 115 1.0× 78 0.7× 139 2.0× 50 0.9× 38 649
Tina Brenneman United States 2 434 1.1× 43 0.4× 88 0.8× 110 1.6× 17 0.3× 2 600
Gemma Carreras Spain 11 189 0.5× 117 1.0× 86 0.8× 31 0.5× 57 1.1× 12 345
Anna Ringborg Sweden 10 152 0.4× 48 0.4× 21 0.2× 25 0.4× 36 0.7× 13 479
Ian Doughty United Kingdom 11 95 0.2× 63 0.5× 94 0.9× 47 0.7× 120 2.2× 21 383
A-M Ugnat Canada 6 168 0.4× 60 0.5× 83 0.8× 32 0.5× 16 0.3× 7 385
Beth Mitchell United States 12 283 0.7× 105 0.9× 118 1.1× 27 0.4× 28 0.5× 43 426
Shweta Mital Canada 11 73 0.2× 42 0.3× 29 0.3× 15 0.2× 27 0.5× 31 391
Elisa Nada Italy 9 342 0.8× 106 0.9× 17 0.2× 87 1.3× 8 0.1× 23 436
Ole Molskov Bech Denmark 10 247 0.6× 57 0.5× 27 0.3× 82 1.2× 8 0.1× 16 402

Countries citing papers authored by P Sharplin

Since Specialization
Citations

This map shows the geographic impact of P Sharplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Sharplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Sharplin more than expected).

Fields of papers citing papers by P Sharplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Sharplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Sharplin. The network helps show where P Sharplin may publish in the future.

Co-authorship network of co-authors of P Sharplin

This figure shows the co-authorship network connecting the top 25 collaborators of P Sharplin. A scholar is included among the top collaborators of P Sharplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Sharplin. P Sharplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Reed, Peter, et al.. (2012). Primary prevention of pediatric abusive head trauma: A cost audit and cost-utility analysis. Child Abuse & Neglect. 36(11-12). 760–770. 41 indexed citations
2.
Sharplin, P, et al.. (2010). Insulin usage in type 2 diabetes mellitus patients in UK clinical practice: a retrospective cohort-based analysis using the THIN database. The British Journal of Diabetes. 10(4). 178–182. 11 indexed citations
3.
Sharplin, P, et al.. (2009). Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study. Cardiovascular Diabetology. 8(1). 3–3. 21 indexed citations
4.
5.
Sharplin, P, et al.. (2008). PCV9 AN ANALYSIS OF THE ANTIHYPERTENSIVE EFFECTIVENESS OF IRBESARTANVS. CANDESARTAN. Value in Health. 11(6). A383–A383. 1 indexed citations
6.
Sharplin, P, et al.. (2008). PCV12 AN ANALYSIS OF THE ANTIHYPERTENSIVE EFFECTIVENESS OF ARBS VS. ACE INHIBITORS. Value in Health. 11(6). A384–A384. 2 indexed citations
7.
Mullins, Peter R., P Sharplin, Hannele Yki‐Järvinen, Matthew C. Riddle, & Hans‐Ulrich Häring. (2007). Negative Binomial Meta-Regression Analysis of Combined Glycosylated Hemoglobin and Hypoglycemia Outcomes Across Eleven Phase III and IV Studies of Insulin Glargine Compared with Neutral Protamine Hagedorn Insulin in Type 1 and Type 2 Diabetes Mellitus. Clinical Therapeutics. 29(8). 1607–1619. 115 indexed citations
8.
9.
10.
11.
Currie, Craig J., Christopher Ll. Morgan, Chris D. Poole, et al.. (2006). Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Current Medical Research and Opinion. 22(8). 1523–1534. 242 indexed citations
12.
Holmes, Jeremy, et al.. (2004). A Cost-Effectiveness Analysis of Docetaxel in the Second-Line Treatment of Non-Small Cell Lung Cancer. PharmacoEconomics. 22(9). 581–589. 37 indexed citations
13.
Currie, Craig J., Christopher Ll. Morgan, Simon Dixon, et al.. (2004). The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications. Diabetes Research and Clinical Practice. 67(2). 144–151. 20 indexed citations
14.
Currie, Craig J., Christopher Ll. Morgan, Simon Dixon, et al.. (2004). Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before death. Diabetes Research and Clinical Practice. 65(3). 267–274. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barrie Chubb Breakdown of academic impact, for papers by Tina Brenneman Breakdown of academic impact, for papers by Gemma Carreras Breakdown of academic impact, for papers by Anna Ringborg Breakdown of academic impact, for papers by Ian Doughty Breakdown of academic impact, for papers by A-M Ugnat Breakdown of academic impact, for papers by Beth Mitchell Breakdown of academic impact, for papers by Shweta Mital Breakdown of academic impact, for papers by Elisa Nada Breakdown of academic impact, for papers by Ole Molskov Bech
Rankless by CCL
2026